Market Research Logo

Orifarm Group AS - Strategic SWOT Analysis Review

Orifarm Group AS - Strategic SWOT Analysis Review

- provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights

Orifarm Group A/S (Orifarm Group) is the parallel importer of pharmaceuticals and the supplier of pharmaceuticals. It comprises several companies engaged in the import, manufacture, re-packaging, distribution, registration and commercialization of pharmaceuticals in the UK, Scandinavia, Germany, Holland and Czech Republic. The company is engaged in parallel importing of pharmaceuticals from European (EU) countries and are sold in Sweden, Finland, Holland, Denmark, Norway, Germany and the UK. Orifarm Group also sells generic pharmaceuticals in the Nordics. It sells a range of generic over-the-counter (OTC) products under Taek gult and Tank Gult brands. Orifarm Group is head quartered in Odense, Denmark.

Orifarm Group AS Key Recent Developments


May 31,2016: Progress continues at Orifarm
May 31,2016: Continuous growth for Orifarm Group

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.


Section 1 - About the Company 5
Orifarm Group A/S - Key Facts 5
Orifarm Group A/S - Key Employees 6
Orifarm Group A/S - Major Products and Services 7
Orifarm Group A/S - History 8
Orifarm Group A/S - Company Statement 9
Orifarm Group A/S - Locations And Subsidiaries 10
Head Office 10
Other Locations & Subsidiaries 10
Section 2 – Company Analysis 11
Orifarm Group A/S - Business Description 11
Orifarm Group A/S - Corporate Strategy 12
Orifarm Group A/S - SWOT Analysis 13
SWOT Analysis - Overview 13
Orifarm Group A/S - Strengths 13
Orifarm Group A/S - Weaknesses 14
Orifarm Group A/S - Opportunities 15
Orifarm Group A/S - Threats 16
Orifarm Group A/S - Key Competitors 17
Section 3 – Company’s Lifesciences Financial Deals and Alliances 18
Orifarm Group A/S, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 18
Orifarm Group A/S, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 19
Orifarm Group A/S, Recent Deals Summary 20
Section 4 – Company’s Recent Developments 21
May 31, 2016: Progress continues at Orifarm 21
May 31, 2016: Continuous growth for Orifarm Group 22
Section 5 – Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23
List of Tables
Orifarm Group A/S, Key Facts 5
Orifarm Group A/S, Key Employees 6
Orifarm Group A/S, Major Products and Services 7
Orifarm Group A/S, History 8
Orifarm Group A/S, Subsidiaries 10
Orifarm Group A/S, Key Competitors 17
Orifarm Group A/S, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 18
Orifarm Group A/S, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 19
Orifarm Group A/S, Recent Deals Summary 20
List of Figuress
Orifarm Group A/S, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Orifarm Group A/S, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report